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Purpose

Wearing off of Parkinson’s disease medication is common, but triggers and coping strategies for
this transient phenomenon are poorly understood. We aimed to assess the lived experience of OFF
periods for people with Parkinson’s disease.

Methods

 articipants in the longitudinal Fox Insight study who endorsed OFF periods were invited to complete
P
a survey consisting of both multiple-choice and free-text responses. Descriptive statistics were used
to summarize multiple-choice responses, and free-text responses were classified into themes through
iterative discussion by 3 movement disorders specialists.

Results

 total of 2110 participants (52.4% male) completed the survey. Tremor was the most common
A
description of OFF periods (n=1038, 49.2%), followed by gait changes (n=535, 25.4%) and rigidity
(n=430, 20.4%). Of 1498 specific triggers for OFF symptoms, the most common was stress (n=920,
61.4%), followed by anxiety/depression (n=476, 31.8%) and tiredness/fatigue (n=351, 23.4%).
Common coping strategies (n=1416 responses) included exercise (n=678, 47.9%), taking a break
(n=504, 35.6%), and meditation (n=276, 19.5%).

Conclusions

 lthough OFF periods are common, the individual experiences of OFF vary. This knowledge could
A
be used to develop new counseling strategies for OFF periods in people with Parkinson’s disease.
(J Patient Cent Res Rev. 2021;8:232-238.)
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W

ith progression of Parkinson’s disease (PD),
more than two-thirds of patients develop
motor fluctuations,1 particularly OFF periods,
during which medications wear off gradually or abruptly,
resulting in the return of parkinsonian features.2 The
severity and unpredictability of OFF time are major
drivers of health-related quality of life among people
with PD;3 thus, the recognition and management of
OFF symptoms is critical. Despite therapeutic advances
over the last half-century, OFF symptoms remain a
potentially disabling feature of the illness,4 with patients
relying on novel formulations of levodopa5 or turning to
surgical strategies6 to address inadequate or unpredictable
responses to medical therapy.

While extensive clinical research has been done on
OFF periods, the “lived experience” of OFF periods for
people with PD (ie, how they experience OFF periods,
communicate about them, and manage them) is not
well understood. Classic OFF motor symptoms are
frequently recognized by clinicians and can be tracked
by questionnaires,7 yet OFF nonmotor symptoms are
less commonly assessed, even though they may be
more disabling to patients,8 and OFF episodes may go
undetected by clinicians. Several factors may account for
this, including perceived barriers to communication about
OFF episodes.9 An investigation of the lexicon patients
use to communicate about OFF periods, and how they
describe their experience during OFF episodes, could
improve detection of OFF episodes through physician
education and the refinement of patient-reported outcomes
to better reflect patient perceptions and description of
their OFF symptoms.
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Additionally, little is known about triggers and
alleviating factors for OFF periods, aside from their
temporal association with medication doses. A better
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understanding of OFF triggers and the strategies patients
use to treat symptoms or lessen their severity could help
identify nonpharmacological strategies to manage these
OFF periods in PD.

PD symptoms? [yes/no] (if yes): Other than taking
medication, what do you do during your OFF
periods to help manage your PD symptoms? [free
text, unlimited characters].

The objective of this study was to elucidate the ways
people with PD describe their OFF periods, including
triggers and coping strategies.

Inclusion criteria for this study were the availability
of data on age, sex, and endorsed OFF periods and a
response provided to at least 1 of the 4 aforedescribed
assessments. Exclusion criteria were absence of a selfreported PD diagnosis at any Fox Insight visits up to the
time of survey, missing participant age, or implausible
age of PD onset.

METHODS

The study design has previously been described in
detail.8 Briefly, participants were recruited from the
Fox Insight study,10 an online-only cohort study of
individuals 18 years of age and older with self-reported
PD versus healthy controls. Demographic information
for the present analysis, including age, education level,
disease duration of PD, and specialty of the clinician who
diagnosed PD, were collected on all participants as part
of the Fox Insight study.
On November 26, 2018, a questionnaire was deployed via
email to a subset of the Fox Insight cohort who had selfreported PD, reported taking 1 or more PD medications,
and were living in the United States. Those who clicked
on the email were taken to the following screening
question: Many individuals with Parkinson’s disease
fluctuate between periods in which their symptoms are
better controlled and periods during which symptoms
return. We refer to the periods during which symptoms
are better controlled as ON, and periods during which
symptoms return as OFF. Based on this definition of
OFF, do you experience OFF periods?
Those responding “no” were excluded from participation in
this survey study; those responding “yes” received a series
of free-text and multiple-choice questions assessing their
experiences of fluctuations and OFF periods. The online
survey was open for 4 weeks, and subjects could return to
the questionnaire as many times as needed over that time to
complete responses. Survey assessments analyzed included:
1. When you talk with your family and friends, what
do you call the periods where your PD symptoms
return? [multiple-choice: OFF periods, OFF
episodes, OFF time, something else (please specify,
free text, unlimited characters)].
2. In the space provided below please describe your
experience when you are OFF [free text, unlimited
characters].
3. Are there triggers, such as anxiety or stress, which
can bring on an OFF period for you? [yes/no] (if
yes): What are those triggers? [free text, unlimited
characters].
4. Other than taking medication, is there anything you
do during your OFF periods to help manage your
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Descriptive statistics were used to summarize
demographics and proportion responding to each answer
on multiple-choice questions. Free-text responses were
reviewed by authors M.L. and B.E. and grouped into
categories or themes, which were reviewed and refined
through iterative classification by movement disorders
specialists (S.M., L.M.C.). Responses could be classified
into multiple categories if appropriate. If a response was
not provided on a given question, that item was considered
missing for that subject.

RESULTS

Of the 13,359 eligible and invited Fox Insight participants,
2684 started the survey (20% response rate). Of these,
507 surveys were terminated when respondents reported
no OFF periods and an additional 49 did not answer
any questions in the survey. Of the remaining 2128, 15
had inconsistency in self-reported diagnosis across Fox
Insight study visits, 6 had missing age at survey, and 3
reported their year of birth as the year of PD onset. Thus,
the final sample for this analysis was 2110 respondents.
Mean age of respondents was 66.6 (standard deviation
[SD]: 8.5) years, 52.4% were male, 1157 (58.6%) had
13–16 years of education, and 655 (33.2%) had more
than 16 years of education (Table 1). Mean disease
duration at the time of survey was 6.1 (SD: 5.1) years.
Mean duration of OFF time was 3.5 (SD: 2.9) hours, and
OFF time accounted for a mean of 22.3% (SD: 20.2%)
of awake hours. Hours of OFF time was missing for
21 respondents. The most commonly used medication
was carbidopa-levodopa (n=1900, 90.1%); 354 (16.8%)
respondents reported use of amantadine.
There were 2101 responses to the question “When you talk
with your family and friends, what do you call the periods
where your PD symptoms return?” Of these, 122 (5.8%)
selected “OFF episodes,” 767 (36.5%) “OFF periods,” 497
(23.7%) “OFF time,” and 715 (34.0%) “something else.”
For those who indicated something else, 455 specified a
free-text response (Table 2). The most common category
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Table 1. Sample Characteristics (N=2110)
Characteristic
Mean age (in years)
Sex
   Female
   Male
Race
   White or Caucasian
   Black or African American
   Multiracial
   Prefer not to answer or N/A
Education level
   <9 years
   9–12 years
   13–16 years
   >16 years
   Prefer not to answer or N/A
Mean disease duration (in years)
Current medications
   Carbidopa-levodopa
   Amantadine
   Pramipexole
   Ropinirole
   Selegiline or rasagiline
   Entacapone or tolcapone
   Rotigotine
   Safinamide
   Apomorphine (subcutaneous)
   Other
   Do not take any medication for Parkinson’s

n (%) or
mean (SD)
66.6 (8.5)
1005 (47.6)
1105 (52.4)
2060 (97.7)
11 (0.5)
3 (0.1)
35 (1.7)
9 (0.5)
147 (7.5)
1157 (58.6)
655 (33.2)
5 (0.3)
6.1 (5.1)
1900 (90.1)
354 (16.8)
346 (16.4)
312 (14.8)
306 (14.5)
188 (8.9)
123 (5.8)
32 (1.5)
23 (1.1)
129 (6.1)
27 (1.3)

N/A, not applicable; SD, standard deviation.

of free-text response was medication-related (examples:
need meds, end of meds, feels like I forgot to take meds),
which was referenced by 78 respondents (17.1%).
Specific symptoms were referenced by 99 respondents
(21.8%), with motor symptoms (shaking, stiffness,
drooping) comprising 76 responses, nonmotor symptoms
(brain-dead, fuzzy) comprising 14 responses, and gait
symptoms (frozen, stuck, legs do not work) comprising
9 responses. Also, 86 respondents (18.9%) reported that
they did not discuss their OFF periods with others or do
not have specific language to describe OFF periods.
There were 2110 responses to the question asking
participants to describe their experience when they are in
an OFF state (Online Supplemental Table S1). Of these,
1926 (91.3%) described specific symptoms, with tremor
(49.2%), gait and freezing problems (25.4%), and rigidity
(20.4%) being most common motor symptoms and
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fatigue (18.8%), mood/anxiety (15.1%), and cognitive
symptoms (15.5%) being the most common nonmotor
symptoms. Additionally, 356 (16.9%) referenced the
phenomenon of motor fluctuations, mentioning either
time of day or timing of medication.
Of the 2097 who provided a response regarding triggers
of OFF periods, 1568 (74.8%) reported triggers for their
OFF periods. Specific triggers were described by 1498
(71.4%) respondents, which are summarized in Table 3.
The most commonly reported trigger was stress (n=920,
61.4%), followed by anxiety/depression (n=476, 31.8%)
and tiredness/fatigue (n=351, 23.4%). Medication timing
was noted as a trigger by only 31 (2.1%) respondents.
In regard to coping strategies, of 2106 respondents,
1447 indicated they have strategies to manage OFF
periods other than taking medication and 1416 (67.2%)
described these strategies (as detailed in Table 3). The
most common coping strategy was exercise (n=678,
47.9%), followed by taking a break (n=504, 35.6%) and
meditation (n=276, 19.5%).

DISCUSSION

People with PD described a variety of symptoms and
triggers of OFF periods as well as many coping strategies
to help deal with and palliate the symptoms of these
OFF periods. Survey respondents reported spending
nearly a quarter of their waking hours in the OFF state,
which comprised both motor and nonmotor features.
Tremor, rigidity, and gait problems were commonly
reported motor symptoms, which is consistent with other
work on bothersome aspects of OFF periods.8 As for
nonmotor symptoms, pain and other sensory symptoms
were mentioned by 24.9% of patients. The mechanism
underlying this association is poorly understood — pain
in PD does not always correlate with motor symptoms11
— although pain is a significant factor in poor quality
of life among people with PD. Overall, our results are
consistent with prior studies that suggested OFF periods
are multifaceted2 and that careful communication is
needed to elucidate exactly which symptoms are most
bothersome to patients.8,9
In our study, 26.9% of respondents explicitly connected
their OFF symptoms with medications when discussing
their experience with others, and 16.9% referenced
motor fluctuations when describing their OFF
symptoms. Importantly, commonly named triggers
included stress, anxiety, and other mood symptoms. The
majority of patients identified coping strategies that do
not involve the use of medications, such as exercise,
meditation, or removing themselves from a stressful
situation. When drugs or supplements were mentioned,
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Table 2. Free-Text Descriptors of Terminology Used by Respondents (n=455) to Describe OFF Periods
Category

Sample text

Medication-related,
nonspecific

I usually just say that I need to take my medication, need meds, end of meds,
feels like I forgot to take meds

78 (17.1)

Symptom-based,
motor
Don’t discuss it

just say that my arm is shaking, symptomatic, twitchy, dyskinesia, drooping,
stiffness, shaky, weak, spastic, have the shakes, have to move
don’t say anything, don’t talk to them, don’t talk to others about it, don’t speak
of them very often, don’t talk to family or friends, never really discussed it, I
don’t mention them
just off, having an off day, feeling off, different, out of tune

76 (16.7)

my meds are off, my meds wore off, medicine wearing off

42 (9.2)

don’t feel good at all, crashing, feel bad, feeling bad, not doing well, not feeling
well, having trouble
bad day, bad days, good days and bad days, hard day, tough day

29 (6.4)

No specific name,
don’t think about it
Heightened sense of
Parkinson’s
No specific name, but
feel it is recognized
Down time

don’t call it anything, don’t have a name, hadn’t given it a name, nothing

27 (5.9)

Parkinson’s symptoms, being parkinsony [sic], god damn parkinsons [sic]

23 (5.1)

I don't really have a name for it, we all just know what is going on, active, don’t
use a consistent descriptor
down time, low time

17 (3.7)

Symptom-based,
cognitive
Frozen

inability, worthless, brain dead, tired, fuzzy

14 (3.1)

gait freeze, frozen, legs do not work, slow motion mode, slow motion, stuck

9 (2.0)

Bad time
Rough time
Funk
Breakthrough
Flare

bad time, bad times, good times and not so good times
rough times, having a rough time, tough time
being funky, in a funk
breakthrough, break thru [sic]
flare-ups, acting up

8 (1.8)
5 (1.1)
4 (0.9)
3 (0.7)
3 (0.7)

“It’s back”
Other

they’re back, its [sic] back
tide is out, got me, adjustments, morning blahs, I told my doctor but he didn’t
seem to think it was significant, guests, transitions, I’m in a tunnel, not online,
wiped out, being pokey, I feel stuff

2 (0.4)
15 (3.3)

OFF
Medication-related,
OFF-specific
General unwell
Bad days

these consisted most commonly of cannabinoids;
anxiolytics, pain medications or supplements, were
less common. The reliance on non-levodopa-based
strategies for coping with OFF periods likely reflects the
nonmotor characteristics of OFF periods for people with
PD and identifies possible areas for future therapeutic
development.
By contrast, most literature for clinicians on
the management of OFF periods focuses on the
pharmacodynamics and pharmacokinetics of levodopa in
advanced PD.2,4,6 This highlights a potential unmet need
to develop treatment strategies that address nonmotor
triggers of OFF periods, beyond novel formulations of
levodopa. In particular, the most commonly reported
coping strategy for OFF symptoms was exercise. This
is consistent with other work12,13 that promotes the
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n (%)

59 (13.0)

44 (9.7)

28 (6.2)

14 (3.1)

importance of exercise for people with PD. Nevertheless,
lack of clinician discussion about exercise is commonly
reported by patients as a barrier to physical activity.14-17
More counseling of patients around exercise, meditation,
or other stress-management techniques may be helpful
in reassuring patients and their families that there are
effective nonpharmacological and nonsurgical strategies
to manage OFF periods.
Interestingly, although all respondents agreed that they
experienced OFF periods as a precondition of receiving
the survey, 1 in 4 reported that they had either not
discussed OFF periods with others or that they had no
specific language for doing so. Better ascertainment
strategies, perhaps enhanced by wearable sensor data,18,19
are needed to ensure clinicians are aware of OFF periods
when present in their patients.
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Table 3. Free-Text Triggers (n=1498) and Coping Strategies (1416) for OFF Periods
Triggers

Sample text

Stress
Anxiety or depression
Tiredness/fatigue
Social situations
Cold or heat exposure
Family issues
Anger
Food intake
Medication-related
Driving
Other, miscellaneous

Any stress is the biggest thing that throws me off
Anxiety, when I get worried about things
Too little sleep, fatigue is biggest trigger
Having dinner out with friends, crowds, unexpected visitors
Cold weather
My son, having an argument with a loved one, mother-in-law, family drama
Confrontations
Hunger, food delay, irregular meals
Trying to get something done before Med time
Driving in traffic
Loud noises, too much noise, airports, airline travel, alcohol, time of day
(more off in the evenings)

Coping strategies
Exercise

Sample text
Stretching, walking, yoga, cycling, biking, hiking, keep moving, staying active,
physical therapy exercises, vigorous exercise, lifting weights, LSVT exercises
Take a break/relax
Calm myself, try to relax, remove myself from the situation, rest quietly,
rest, sit down, lie very still with my eyes closed, get away from everyone,
quiet time, just ignore it, slow down, avoid stress
Mindfulness/positive
Respiratory, deep breaths, breathing exercises, tell myself to have good
thinking/breathe/
posture, talk out loud to myself, concentrating on relieving the tightness,
massage
massage, relaxation exercises, try to stay calm and be as positive as possible,
tai chi, mindfulness, focus on breathing, mental simulation, hold my hands
folded and calming myself, mindfulness music, eliminate stress, qigong
Sleep/nap
Take a nap, force myself to sleep, bed rest, lay down in bed, rest or sleep
sometimes charges me back up
Drink/eat
Hydration, water, diet program designed for people with Parkinson’s, suck
on a piece of candy, eating, martinis, alcoholic drink, tea, carbonated
beverages, citrus, protein
Activity
Crosswords, puzzles, word searches, gardening, making art, genealogy
project, cleaning, stay occupied with activity, focus on some work,
counting, puzzles, tasks, chores, singing
Read
Reading for pleasure, reading a book
Technology
I play on my computer, listen to audiotape, surf internet, listen to online
stories, television, use phone, funny movies
Music
Soothing music, listen to online music, mindfulness music
Heat
Heating pad, hot bath, hot tub, get warm if I’m cold, heat therapy, sauna,
shower
CBD/cannabis
CBD oil, vape cannabis, CBD gummies, marijuana, THC
Social
Being engaged socially with others, socializing, conversation, talk with friends
Focus on movements Deliberate movement to oppose dystonia, flexion, extension, holding
hands in certain positions, focus on not falling while walking
Anti-anxiety medication Klonopin, Xanax, valium
Animals
Walk the dog, go to the barn, hold my cats
Pray
--Pain medications
Advil, gabapentin, Bengay, ibuprofen, Tylenol
Supplements
Essential oils, B12, dopatone, glutathione, mucuna, quinine, fish oil, coconut oil
Deep brain stimulation --Other
Change, use red pointer to lead the way, keeping, vibrating chair/pads
for tremors, ice pack, avoid driving, sex, acupuncture, rework lifestyle,
quick release pills, gas x, foam roller, hold a baby, extra dose of Sinemet,
intellectual willpower, compression device, laxative, cognitive behavior
therapy, bowel movement, cry, swear

n

% of 1498

920
476
351
118
102
96
71
57
31
16
92

61.4
31.8
23.4
7.9
6.8
6.4
4.7
3.8
2.1
1.1
12.3

n
678

% of 1416
47.9

504

35.6

276

19.5

256

18.1

97

6.9

94

6.6

61
58

4.3
4.1

52
49

3.7
3.5

48
28
26

3.4
2.0
1.8

19
15
15
10
6
5
67

1.3
1.1
1.1
0.7
0.4
0.4
4.7

CBD, cannabidiol; LSVT, Lee Silverman Voice Treatment. THC, tetrahydrocannabinol.
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Strengths and Limitations

To our knowledge, this is the first large-scale study of
the experience of OFF periods in people with PD and
builds on prior qualitative work examining the OFF
experience.4,8 Because OFF symptoms are strongly
associated with health-related quality of life among
people with PD,3 this study provides a glimpse into
understanding this common and critical aspect of the
disease. Noted strengths of the current study include a
large cohort that comprised nearly 50% women, a group
otherwise underrepresented in PD research. Additionally,
few prior studies examine the impact and experience
of OFF periods from the patient’s perspective;20 this
questionnaire was built directly on interviews with
patients21 and thus captures a range of lived experience
reported by patients rather than assumed by clinicians.
Nevertheless, some important study limitations should
be acknowledged. First, the self-reported nature of Fox
Insight makes the validity of a PD diagnosis somewhat
uncertain; however, we note that nearly all reported
that they had been diagnosed by a neurologist or
movement disorders specialist, suggesting a relatively
good confidence in the validity of the diagnosis, and the
pattern of responses from the online Fox Insight cohort is
similar to well-defined PD cohorts assessed in person.22
Specifically for this study, individuals without PD would
not experience OFF periods and thus would have been
screened out before starting the survey. Second, we were
unable to independently assess or confirm the wearing
off symptoms reported by participants. However, the
congruent responses to questions about the experience
of OFF periods and the consistency with reports from
other surveys about OFF periods provides face validity
to the self-report in this analysis. Finally, this cohort
consisted mainly of highly educated English-speaking
Caucasians living in the United States; thus, our findings
may not be generalizable to other PD subpopulations.

CONCLUSIONS

This study adds important knowledge about the way
people with Parkinson’s disease experience OFF periods
and how patients cope with these symptoms. Although
participants described their OFF symptoms, triggers, and
coping strategies in detail, a substantial proportion had
not previously discussed this important aspect of illness
experience with others. OFF symptoms described by
participants included both motor (tremor, gait, rigidity)
and nonmotor (pain, fatigue, mood, cognitive) domains,
while common coping strategies included exercise,
taking a break, and mindfulness meditation.
The development of comprehensive counseling strategies
for patients and care partners centered around OFF
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communication, encompassing both preventing OFF and
coping with the OFF periods that do occur, is an unmet
need among people with PD. Such work could better
inform patient and family counseling on the recognition
and management of OFF periods with respect to taking
medication for PD.
Patient-Friendly Recap
• Patients receiving treatment for Parkinson’s
disease commonly experience “OFF” periods
during which their medications lose effectiveness
and their symptoms re-emerge.
• The authors surveyed more than 2000 people with
Parkinson’s and a history of OFF periods.
• The most frequently self-reported triggers of OFF
were stress, anxiety/depression, and tiredness.
Returning symptoms included tremor, changes in
gait, and rigidity. Exercise and meditation were two
common coping strategies.
• Patients who are prescribed Parkinson’s medication
should be counseled on ways to manage potential
OFF periods.
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